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Abstract The Epstein-Barr virus nuclear antigen 1 (EBNA1) is
a multifunctional protein involved in the replication and
maintenance of the viral episome. We identified a potential
Rev-like nuclear export signal (NES) which, however, does not
confer the export of EBNA1. In the yeast two-hybrid system
EBNA1 does not bind to the nuclear exporter Crm1p. In spite of
the RNA-binding ability of EBNA1 and its structural homologies
to RNA binding proteins like hnRNP U and/or A1, EBNA1 does
not shuttle to the cytoplasm in heterokaryon analysis. We
propose the function of the RNA binding of EBNA1 in retaining
RNAs to the nucleus.
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1. Introduction
The Epstein-Barr virus (EBV) is the causative agent of in-
fectious mononucleosis and is furthermore implicated in the
pathogenesis of several human malignancies (reviewed in [1]).
EBNA1 is the only latent protein which is expressed in all
types of latency found in human EBV-positive malignancies.
EBNA1 is a multifunctional phosphoprotein [2] with a va-
riety of properties including sequence-speci¢c binding to
DNA [3] [4], formation of homodimers [5], nuclear localiza-
tion [6] and stimulation of cellular gene expression [7].
EBNA1 binds to the viral origin of replication (oriP) [8] [9]
and is the only virus protein necessary and su⁄cient to repli-
cate and maintain the EBV genome in the infected cell [10].
Recently, it was shown that one of the roles in oriP replication
mediated by EBNA1 is to prevent the degradation of newly
synthesized oriP plasmids [11]. The initiation of the DNA
synthesis at oriP can be induced by cellular factors but prob-
ably facilitated by EBNA1. So far, there is no helicase or
ATPase activity known for EBNA1.
Using the yeast two-hybrid system we identi¢ed the ¢rst
EBNA1 associated protein, the nuclear transporter karyo-
pherin K2/Rch1 [12]. We demonstrated that the binding to
karyopherin K2 was mediated through a C-terminal region
of EBNA1 encompassing the nuclear localization signal
(NLS). Experiments analyzing the cellular distribution of
EBNA1 revealed that a small portion of the protein could
be found in the soluble cytoplasmic fraction [12]. Immunohis-
tochemical staining of EBNA1 positive tumor cells also
showed a weak cytoplasmic staining of EBNA1 [13,14].
EBNA1 shares signi¢cant structural similarity to the RNA-
binding domains of the U1A spliceosomal protein and heter-
ogeneous ribonucleoprotein (hnRNP) [15]. RNA-binding pro-
teins, like hnRNPA1, were shown to shuttle between nucleus
and cytoplasm, suggesting that they may be involved in nu-
cleocytoplasmic tra⁄cking of mRNA [16]. Other hnRNP pro-
teins, like hnRNP U are restricted to the nucleus implicating
that one of their function may be retaining incompletely proc-
essed pre-mRNA in the nucleus. These proteins are to be
removed from the RNA before translocation to the cyto-
plasm. One of the best characterized nuclear export mecha-
nisms is the Rev-like pathway based on a small transferable
leucine rich nuclear export signal (NES) which confers bind-
ing to the nuclear export factor Crm1p [17]. In an energy-
dependent mechanism proteins bearing a NES are transported
to the cytoplasm. A potential Rev-like NES is located in the
C-terminal region of EBNA1 (aa 533^540) (see Fig. 1). Fur-
thermore, EBNA1 was found as a component of an RNA
complex and it could be demonstrated that EBNA1 binds to
the EBV-encoded RNA-polymerase III transcript, EBER 1, as
well as to exon sequences derived from its own RNA [18].
Since EBNA1 encompasses a potential NES, binds to RNA
and is partially found in the cytoplasm, we speculated that the
cytoplasmic form of EBNA1 might be involved in the trans-
location of RNA from the cell nucleus to the cytoplasm. Our
aim was to investigate whether the nuclear form of EBNA1
indeed shuttles to the cytoplasm. We found by heterokaryon
assays, however, that EBNA1 is retained in the nucleus. Also,
no binding of EBNA1 to the export factor Crm1p in a yeast
two-hybrid assay was detectable. We propose that the func-
tion of the RNA binding ability of EBNA1 may lie in retain-
ing incompletely processed pre-mRNA in the nucleus, like its
own RNA transcribed from the Fp promoter.
2. Materials and methods
2.1. Plasmid construction
The plasmid pEGFP-EBNA1 containing a truncated form of
EBNA1 was constructed as follows: the EBNA1 gene with only
5 GGA repeats, normally located between aa 90 and 328, from the
expression vector p1553 [11] was PCR ampli¢ed and cloned in frame
into the EcoRI, SalI digested pEGFP-C1 vector (Clontech). The vec-
tor p1553 was a generous gift of B. Sugden (Madison, WI, USA). The
primers used were: 5P-GCGAATTCCATGTCTGACGAG-3P and 5P-
CACGCCAGCTGTCACTCCTGCCCCTTCTCACC-3P.
The plasmids encoding adenovirus E4orf6 as well as E4orf6, mu-
tated within the potential NES coding region, were kindly supplied by
M. Dobbelstein (Marburg, Germany).
2.2. Cells and antibodies
HeLa cells and murine BALB/c 3T3 cells were grown in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal calf serum and
were subcultured routinely once per week. The rat monoclonal anti-
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body (MAb) 1H4 directed against EBNA1 has been described [14].
The mouse MAb RSA3 [19] directed against adenovirus E4orf6 was a
generous gift from M. Dobbelstein (Marburg, Germany).
2.3. Protein shuttling assay
Shuttling assays were performed using a heterokaryon assay as
described by Pinol-Roma and Dreyfuss [20]. HeLa cells were trans-
fected with various expression plasmids using the Superfect Transfec-
tion reagent (Qiagen). 24^30 h after transfection, the cells were seeded
on a 3.5 cm tissue culture dish containing a glass cover slip together
with 1U106 BALB/c 3T3 cells in culture medium containing cyclo-
heximide (50 Wg/ml). After 2^3 h the cells were covered with a solution
of 50% (w/v) polyethylene glycol 8000 (Sigma) in PBS for 2 min at
37‡C to induce cell fusion. Subsequently, the coverslips were trans-
ferred back to DMEM/10% FCS containing cycloheximide and fur-
ther incubated for 2 h, 4 h or 6 h at 37‡C. The cells were then ¢xed
with 4% paraformaldehyde in PBS for 15 min, followed by permeabi-
lization with 0.2% Triton X-100 in PBS at 4‡C. The cells were ana-
lyzed by immuno£uorescence using primary antibodies RSA3 [19] at a
1:10 dilution or 1H4, anti-EBNA1, at a 1:10 dilution, for 1 h, washed
three times for 5 min in PBS. Secondary antibodies (FITC-conjugated
goat anti-mouse IgG2a or anti-rat IgG, diluted 1:500) were added for
30 min, followed by three washes as above and subsequently mounted
in DAPI solution (Sigma) for 30 min. The cells transfected with the
pEGFP constructs were directly treated with the DAPI solution after
¢xation.
3. Results and discussion
3.1. Identi¢cation of a potential Rev-like NES in the
C-terminal domain of EBNA1
Previous studies from Ambinder et al. [6] had identi¢ed a
classical nuclear localization sequence (NLS) between aa 379
and 386 of the EBNA1 protein. Consistent with these earlier
results we could show that indeed this NLS mediates the
transport of EBNA1 from the cytoplasm to the nucleus [12].
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Fig. 1. Diagram of the 641 aa EBNA1 protein. The RGG motifs,
the position of the Gly-Ala repeat, the NLS and the DNA binding
domain are indicated. The sequences of the potential NES and of
the consensus Rev-like NES are shown.
Fig. 2. EBNA1 does not tra⁄c between nuclei of heterokaryons. HeLa cells were transfected with expression plasmids for E4orf6 (A,B), and
GFP-EBNA1 (C,D). After heterokaryon formation with murine cells, the cells were incubated for 2 h at 37‡C. Then, the heterokaryons were
¢xed and stained for E4orf6 (A) and for EBNA1 (C) using the monoclonal antibodies RSA3 and 1H4, respectively. This was followed by an
FITC-conjugated secondary antibody for rat IgG. Subsequently, the cells were stained with a DAPI solution 1:25 000 (Sigma) for distinguishing
the nuclei of the di¡erent species (B,D). In contrast to the human nuclei, the nuclei of the murine BALB/c 3T3 showed speci¢c bright speckles.
The images displayed are examples of the results consistently observed in s 100 fused cells viewed over three independent cell fusion experi-
ments.
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EBNA1 is restricted to bright speckles within the nucleus and
also thinly distributed in the whole nucleus, suggesting that
the major part of EBNA1 is probably con¢ned to replication
origins [13,14]. In contrast, cellular fractionation studies [12]
as well as immunohistochemical staining of tumor cells re-
vealed that also a minor part of EBNA1 can be found in
the cytoplasm, indicating that EBNA1 might be exported
out of the nucleus. By analysis of the EBNA1 aa sequence
we found that the carboxy-terminal sequence between aa 533
and aa 540 (L533TPLSRLP) shares signi¢cant similarity with
the consensus Rev-like NES sequence (reviewed in [21]) (Fig.
1). This nuclear export sequence (NES) consists of several
leucine residues with uneven spacing in-between. The consen-
sus pattern L(X)2^3L(X)2^3LXL was ¢rst described for the
HIV-1 Rev and cellular protein kinase inhibitor (PKI) pro-
teins [22,23], and is targeted by Crm1p, a member of the
karyopherin L family [24^27]. These observations suggested
that the presence of EBNA1 in the cytoplasm might be a
consequence of Crm1p-dependent export of EBNA1. There-
fore, we tested the interaction between Crm1p and EBNA1 in
the yeast two-hybrid system. In these experiments di¡erent
fusion proteins of EBNA1 containing this potential NES did
not show an interaction with Crm1p in the yeast two-hybrid
system (data not shown). This implies that EBNA1, if ex-
ported out of the nucleus, does not use the Rev-like pathway.
For the hnRNP A1 it was shown that inhibition of RNA
transcription by actinomycin D, inhibitor of the RNA poly-
merase II, resulted in retention of the protein in the cytoplasm
[20]. We tested whether the nuclear localization of EBNA1 is
also dependent on RNA polymerase II transcription. For this
purpose, we exposed GFP-EBNA1 transfected HeLa cells
with actinomycin D. After treatment of the GFP-EBNA1
transfected cells for 2, 4 or 8 h with actinomycin D, we ob-
served no change in the EBNA1 staining, i.e. EBNA1 was still
predominantly found in the nucleus (data not shown). This
suggested that the cytoplasmic localization of EBNA1 neither
depends on RNA export nor on impaired nuclear import
caused by inhibition of RNA transcription.
3.2. EBNA1 does not shuttle between nucleus and cytoplasm
Since EBNA1 in addition to its potential NES, shows se-
quence similarities to heterogeneous RNA-binding proteins
like hnRNP U and hnRNP A1, we asked whether the cyto-
plasmic localization of EBNA1 is due to the shuttling of the
protein between nucleus and cytoplasm. The sequence of
EBNA1 shows a strong homology with the heterogeneous
nuclear protein, hnRNP U (a member of the hnRNP par-
ticles, controlling post-transcriptional processes) in regard to
RGG consensus RNA binding motifs [17]. Furthermore,
EBNA1 possesses structural homologies to the heterogeneous
ribonucleoprotein hnRNP A1, which is involved in mRNA
export and continuously shuttles between nucleus and cyto-
plasm [13]. Nascent pre-mRNAs associate with the abundant
heterogeneous nuclear RNP (hnRNP) proteins and remain
associated with them as long as they reside in the nucleus.
The hnRNP proteins can be divided into two groups accord-
ing to their nucleocytoplasmic transport properties. One
group is completely restricted to the nucleus in interphase
cells, whereas the other group, although primarily nuclear at
steady state, shuttles between the nucleus and the cytoplasm.
To assay for nucleocytoplasmic shuttling, heterokaryons of
E4orf6 and pEGFP-EBNA1 transfected HeLa cells, respec-
tively, with murine BALB/c 3T3 cells were produced using
polyethylene glycol (see Section 2). The cells were ¢xed and
stained, 2, 4 or 6 h after the fusion followed by a stain with a
DAPI solution thus distinguishing the nuclei of the di¡erent
species from each other. Nucleocytoplasmic shuttling was in-
dicated by the detection of adenovirus E4orf6 in the murine
nuclei, which served as a positive control (Fig. 2A,B). In con-
trast to this, EBNA1 was only found in the originally trans-
fected human HeLa cell nuclei (Fig. 2C,D), indicating that in
spite of the structural similarities between EBNA1 and
hnRNP A1, EBNA1 does not shuttle between nucleus and
cytoplasm.
The function of the RNA binding by the RGG motifs of
EBNA1 seems not to lie within the transport of viral or cel-
lular RNA into the cytoplasm. It was shown that the non-
shuttling group of hnRNP are restricted to the nucleus not
because they lack a NES, but because they bear a nuclear
retention sequence (NRS) that is capable of overriding an
NES [28]. It was demonstrated by Snudden et al. [17] that
EBNA1 could bind to exon sequences derived from its own
RNA, transcribed from the Fp promoter. In regard to this, it
could be possible that the RNA binding activity of EBNA1
leads to regulation of the BamHI W transcripts. It will be of
great interest to further analyze the function of the RNA-
binding activity of EBNA1 in regard to its possible role in
retaining viral or cellular RNAs within the nucleus.
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